Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 76 Records) |
Query Trace: Neoplasms and SETD2[original query] |
---|
Genomic Characterization of de novo Metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 12 27 (4): 1105-1118. Garrido-Castro Ana C, Spurr Liam F, Hughes Melissa E, Li Yvonne Y, Cherniack Andrew D, Kumari Priti, Lloyd Maxwell R, Bychkovsky Brittany, Barroso-Sousa Romualdo, Di Lascio Simona, Jain Esha, Files Janet, Mohammed-Abreu Ayesha, Krevalin Max, MacKichan Colin, Barry William T, Guo Hao, Xia Daniel, Cerami Ethan, Rollins Barrett J, MacConaill Laura E, Lindeman Neal I, Krop Ian E, Johnson Bruce E, Wagle Nikhil, Winer Eric P, Dillon Deborah A, Lin Nancy |
Mutation Profile of Aggressive Pheochromocytoma and Paraganglioma with Comparison of TCGA Data. Cancers 2021 May 13 (10): . Choi Yun Mi, Lim Jinyeong, Jeon Min Ji, Lee Yu-Mi, Sung Tae-Yon, Hong Eun-Gyoung, Lee Ji-Young, Jang Se Jin, Kim Won Gu, Song Dong Eun, Chun Sung-M |
Pan-cancer analysis of SETD2 mutation and its association with the efficacy of immunotherapy. NPJ precision oncology 2021 6 5 (1): 51. Lu Mingdong, Zhao Bin, Liu Mengshan, Wu Le, Li Yingying, Zhai Yingna, Shen Xi |
Spatial Distribution of Private Gene Mutations in Clear Cell Renal Cell Carcinoma. Cancers 2021 5 13 (9): . Moore Ariane L, Batavia Aashil A, Kuipers Jack, Singer Jochen, Burcklen Elodie, Schraml Peter, Beisel Christian, Moch Holger, Beerenwinkel Ni |
Integrative radiogenomics analysis for predicting molecular features and survival in clear cell renal cell carcinoma. Aging 2021 4 13 (7): 9960-9975. Zeng Hao, Chen Linyan, Wang Manni, Luo Yuling, Huang Yeqian, Ma Xuel |
Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo. Cancer discovery 2021 3 11 (7): 1736-1753. Foggetti Giorgia, Li Chuan, Cai Hongchen, Hellyer Jessica A, Lin Wen-Yang, Ayeni Deborah, Hastings Katherine, Choi Jungmin, Wurtz Anna, Andrejka Laura, Maghini Dylan G, Rashleigh Nicholas, Levy Stellar, Homer Robert, Gettinger Scott N, Diehn Maximilian, Wakelee Heather A, Petrov Dmitri A, Winslow Monte M, Politi Kateri |
[Expression and clinical significance of SETD2 in maligant pleural mesothelioma]. Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases 2021 3 39 (2): 91-98. Yu M, Yu M, Zhu L J, Yuan X Y, Zhang |
Genetic alterations in squamous cell lung cancer associated with idiopathic pulmonary fibrosis. International journal of cancer 2021 Feb . Hata Atsushi, Nakajima Takahiro, Matsusaka Keisuke, Fukuyo Masaki, Nakayama Manabu, Morimoto Junichi, Ito Yuki, Yamamoto Takayoshi, Sakairi Yuichi, Rahmutulla Bahityar, Ota Satoshi, Wada Hironobu, Suzuki Hidemi, Iwata Takekazu, Matsubara Hisahiro, Ohara Osamu, Yoshino Ichiro, Kaneda Atsus |
Risk prediction for metastasis of clear cell renal cell carcinoma using digital multiplex ligation-dependent probe amplification. Cancer science 2021 10 113 (1): 297-307. Yoshikawa Yoshie, Yamada Yusuke, Emi Mitsuru, Atanesyan Lilit, Smout Jan, de Groot Karel, Savola Suvi, Nakanishi-Shinkai Yukako, Kanematsu Akihiro, Nojima Michio, Ohmuraya Masaki, Hashimoto-Tamaoki Tomoko, Yamamoto Shin |
The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms. Endocrine-related cancer 2021 Oct . Venizelos Andreas, Elvebakken Hege, Perren Aurel, Nikolaienko Oleksii, Deng Wei, Lothe Inger Marie B, Couvelard Anne, Hjortland Geir Olav, Sundlöv Anna, Svensson Johanna, Garresori Harrish, Kersten Christian, Hofsli Eva, Detlefsen Sönke, Krogh Merete, Sorbye Halfdan, Knappskog Sti |
Immune pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma. Communications biology 2021 Oct 4 (1): 1178. Das Sunetra, Idate Rupa, Regan Daniel P, Fowles Jared S, Lana Susan E, Thamm Douglas H, Gustafson Daniel L, Duval Dawn |
Mutation profile of non-small cell lung cancer revealed by next generation sequencing. Respiratory research 2021 Jan 22 (1): 3. Chang Ya-Sian, Tu Siang-Jyun, Chen Yu-Chia, Liu Ting-Yuan, Lee Ya-Ting, Yen Ju-Chen, Fang Hsin-Yuan, Chang Jan-Gow |
The mutational landscape and prognostic indicators of pseudomyxoma peritonei originating from the ovary. International journal of cancer 2021 1 148 (8): 2036-2047. Wang Bing, Yao Jianfei, Ma Ruiqing, Liu Danni, Lu Yiyan, Shi Guanjun, An Lubiao, Xia Ao, Chen Feng, Pang Shaojun, Zhai Xichao, Liu Guifeng, Chen Shifu, Xu Mingyan, Song Lele, Xu Hongb |
Clinicopathological and prognostic impact of somatic mutations in Chinese patients with clear cell renal cell carcinoma. Translational andrology and urology 2020 Dec 9 (6): 2751-2763. Bi Hai, Yin Jipeng, Zhou Lang, Wu Yaqian, Ge Liyuan, Lu Min, Liu Lei, Zhang Hongxian, Zhao Yongzhe, Liu Cheng, Ma Lul |
Genomic landscape of pleural and peritoneal mesothelioma tumours. British journal of cancer 2022 Sep . Hiltbrunner Stefanie, Fleischmann Zoe, Sokol Ethan S, Zoche Martin, Felley-Bosco Emanuela, Curioni-Fontecedro Alessand |
Pancancer analysis of a potential gene mutation model in the prediction of immunotherapy outcomes. Frontiers in genetics 2022 9 13 917118. Yu Lishan, Gong Caife |
The impact of rare germline variants on human somatic mutation processes. Nature communications 2022 6 13 (1): 3724. Vali-Pour Mischan, Lehner Ben, Supek Fr |
Analysis of recurrent molecular alterations in phyllodes tumour of breast: insights into prognosis and pathogenesis. Pathology 2022 Jun . Tsang Julia Y, Shao Yan, Poon Ivan K, Ni Yun-Bi, Kwan Johnny S, Chow Chit, Shea Ka-Ho, Tse Gary |
Evaluation of a seven gene mutational profile as a prognostic factor in a population-based study of clear cell renal cell carcinoma. Scientific reports 2022 4 12 (1): 6478. van de Pol Jeroen A A, Ferronika Paranita, Westers Helga, van Engeland Manon, Terpstra Martijn M, Smits Kim M, de Lange Kim, van den Brandt Piet A, Sijmons Rolf H, Schouten Leo J, Kok Kla |
Epimutations in both the TESK2 and MMACHC promoters in the Epi-cblC inherited disorder of intracellular metabolism of vitamin B. Clinical epigenetics 2022 4 14 (1): 52. Oussalah Abderrahim, Siblini Youssef, Hergalant Sébastien, Chéry Céline, Rouyer Pierre, Cavicchi Catia, Guerrini Renzo, Morange Pierre-Emmanuel, Trégouët David, Pupavac Mihaela, Watkins David, Pastinen Tomi, Chung Wendy K, Ficicioglu Can, Feillet François, Froese D Sean, Baumgartner Matthias R, Benoist Jean-François, Majewski Jacek, Morrone Amelia, Rosenblatt David S, Guéant Jean-Lou |
Deciphering the etiology and role in oncogenic transformation of the CpG island methylator phenotype: a pan-cancer analysis. Briefings in bioinformatics 2022 2 23 (2): . Yates Josephine, Boeva Valenti |
A genomic mutation spectrum of collecting duct carcinoma in the Chinese population. BMC medical genomics 2022 1 15 (1): 1. Zhang Huaru, Lu Xiaojun, Huang Gang, Hua Meimian, Zhang Wenhui, Wang Tao, Huang Liqun, Wang Ziwei, Chen Qing, Li Jing, Yang Qing, Yang Guoshe |
Identification of Survival-Specific Genes in Clear Cell Renal Cell Carcinoma Using a Customized Next-Generation Sequencing Gene Panel. Journal of personalized medicine 2022 Jan 12 (1): . Hwang Jia, Kim Heeeun, Han Jinseon, Lee Jieun, Hong Sunghoo, Kim Saewoong, Yoon Sungjoo Kim, Choi Keonwoo, Yang Jihoon, Park Unsang, Kim Kwangjoong, Yim Kwangil, Kim Yuil, Choi Yeongj |
T and NK cell abundance defines two distinct subgroups of renal cell carcinoma. Oncoimmunology 2022 1 11 (1): 1993042. Lee Moon Hee, Järvinen Petrus, Nísen Harry, Brück Oscar, Ilander Mette, Uski Ilona, Theodoropoulos Jason, Kankainen Matti, Mirtti Tuomas, Mustjoki Satu, Kreutzman An |
Genomic characterization of thymic epithelial tumors in a real-world dataset. ESMO open 2023 9 8 (5): 101627. K Kurokawa, T Shukuya, R A Greenstein, B G Kaplan, H Wakelee, J S Ross, K Miura, K Furuta, S Kato, J Suh, S Sivakumar, E S Sokol, D P Carbone, K Takahas |
SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy. BMC cancer 2023 7 23 (1): 686. Xiaobin Zheng, Jing Lin, Jiani Xiong, Yanfang Guan, Bin Lan, Yi Li, Xuan Gao, Zhaodong Fei, Lisha Chen, Lizhu Chen, Ling Chen, Gang Chen, Zengqing Guo, Xin Yi, Weiguo Cao, Xinghao Ai, Chengzhi Zhou, Xiaofeng Li, Jun Zhao, Xiangtao Yan, Qitao Yu, Lu Si, Yu Chen, Chuanben Ch |
Genomic profiles of renal cell carcinoma in a small Chinese cohort. Frontiers in oncology 2023 7 13 1095775. Sheng Tai, Dan-Dan Xu, Zhixian Yu, Yu Guan, Shuiping Yin, Jun Xiao, Song Xue, Chaozhao Lia |
Molecular genetics of diffuse sclerosing papillary thyroid cancer. The Journal of clinical endocrinology and metabolism 2023 3 . Alswailem Meshael, Alghamdi Balgees, Alotaibi Anwar, Aljomiah Abeer, Al-Hindi Hindi, Murugan Avaniyapuram Kannan, Abouelhoda Mohamed, Shi Yufei, Alzahrani Ali |
Identifying survival of pan-cancer patients under immunotherapy using genomic mutation signature with large sample cohorts. Journal of molecular medicine (Berlin, Germany) 2023 11 . Liuchao Zhang, Yuanyuan Wang, Liuying Wang, Meng Wang, Shuang Li, Jia He, Jianxin Ji, Kang Li, Lei C |
Clinical and genomic predictors of adverse events in newly diagnosed glioblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 1 . Mary Jane Lim-Fat, J Bryan Iorgulescu, Rifaquat Rahman, Varun Bhave, Alona Muzikansky, Eleanor Woodward, Sydney Whorral, Marie Allen, Mehdi Touat, Xiaomei Li, Gongwen Xu, Jay Patel, Elizabeth R Gerstner, Jayashree Kalpathy-Cramer, Gilbert Youssef, Ugonma Chukwueke, J Ricardo McFaline-Figueroa, Lakshmi Nayak, Eudocia Q Lee, David A Reardon, Rameen Beroukhim, Raymond Y Huang, Wenya Linda Bi, Keith L Ligon, Patrick Y W |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: